Genetics of Prostate Cancer (PDQ®)–Health Professional Version

SECTIONS

Changes to This Summary (07/14/2016)

The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

Introduction

Updated National Comprehensive Cancer Network (NCCN) as reference 36.

Genes With Potential Clinical Relevance in Prostate Cancer Risk

Updated NCCN as reference 31.

Revised Table 12, Case-Control Studies of BRCA1 and BRCA2 and Survival Outcomes, to include a study of 1,302 men from the United Kingdom with local or locally advanced prostate cancer (cited Castro et al. as reference 33).

Interventions in Familial Prostate Cancer

Revised Table 13, Summary of Prostate Cancer Screening Recommendations for High-Risk Men, to include men with a family history of BRCA mutations and updated NCCN Clinical Practice Guidelines in Oncology as references 11 and 12.

This summary is written and maintained by the PDQ Cancer Genetics Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ® - NCI's Comprehensive Cancer Database pages.

< Previous section
Psychosocial Issues in Familial Prostate Cancer

Next section >
About This PDQ Summary

Genetics of Prostate Cancer (PDQ®)—Health Professional Version - National Cancer Institute